EDSA Insider Trading

Insider Ownership Percentage: 29.50%
Insider Buying (Last 12 Months): $121,267.50
Insider Selling (Last 12 Months): $0.00

Edesa Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Edesa Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edesa Biotech Share Price & Price History

Current Price: $1.15
Price Change: Price Increase of +0.01 (0.88%)
As of 10/5/2022 01:00 AM ET

This chart shows the closing price history over time for EDSA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Edesa Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/30/2022Pardeep NijhawanCEOBuy20,000$1.60$32,000.00594,812View SEC Filing Icon  
6/29/2022Michael J. BrooksPresidentBuy3,000$1.49$4,470.0026,241View SEC Filing Icon  
6/16/2022Michael J. BrooksPresidentBuy3,000$1.61$4,830.0023,241View SEC Filing Icon  
5/27/2022Pardeep NijhawanCEOBuy5,000$1.92$9,600.00574,812View SEC Filing Icon  
5/25/2022Michael J. BrooksPresidentBuy3,500$1.74$6,090.0020,241View SEC Filing Icon  
5/24/2022Pardeep NijhawanCEOBuy2,000$1.80$3,600.00569,812View SEC Filing Icon  
3/31/2022Pardeep NijhawanCEOBuy2,000$2.99$5,980.00View SEC Filing Icon  
3/29/2022Pardeep NijhawanCEOBuy2,000$3.02$6,040.00View SEC Filing Icon  
3/17/2022Pardeep NijhawanCEOBuy2,000$3.26$6,520.00View SEC Filing Icon  
3/15/2022Pardeep NijhawanCEOBuy2,000$2.80$5,600.00View SEC Filing Icon  
3/14/2022Michael J. BrooksPresidentBuy1,250$2.79$3,487.50View SEC Filing Icon  
3/11/2022Pardeep NijhawanCEOBuy7,000$3.09$21,630.00View SEC Filing Icon  
3/10/2022Michael J. BrooksPresidentBuy1,000$3.22$3,220.00View SEC Filing Icon  
3/9/2022Pardeep NijhawanCEOBuy1,500$3.05$4,575.00View SEC Filing Icon  
3/8/2022Michael J. BrooksPresidentBuy1,250$2.90$3,625.00View SEC Filing Icon  
3/29/2021Pardeep NijhawanCEOBuy2,000$5.23$10,460.00547,312View SEC Filing Icon  
3/25/2021Michael J. BrooksPresidentBuy3,500$5.19$18,165.0013,241View SEC Filing Icon  
3/24/2021Pardeep NijhawanCEOBuy5,000$5.16$25,800.00542,312View SEC Filing Icon  
2/18/2021Frank R OakesDirectorSell7,992$7.25$57,942.00
5/27/2020Michael J. BrooksPresidentBuy2,500$3.19$7,975.00
5/26/2020Pardeep NijhawanCEOBuy3,000$3.18$9,540.00537,312View SEC Filing Icon  
3/17/2020Pardeep NijhawanCEOBuy5,000$1.87$9,350.00537,312View SEC Filing Icon  
1/8/2020Der Velden Peter VanDirectorBuy140,625$3.20$450,000.008,524View SEC Filing Icon  
1/8/2020Michael J. BrooksPresidentBuy1,827$4.11$7,508.971,827View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Edesa Biotech (NASDAQ:EDSA)

9.10% of Edesa Biotech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EDSA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Edesa Biotech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2022Millennium Management LLC53,762$86K0.0%N/A0.348%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC46,248$74K0.0%-44.1%0.299%Search for SEC Filing on Google Icon
8/8/2022Merit Financial Group LLC20,409$33K0.0%N/A0.132%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC82,800$0.25M0.0%+150.2%0.595%Search for SEC Filing on Google Icon
5/5/2022National Bank of Canada FI10,000$30K0.0%+1,518.1%0.072%Search for SEC Filing on Google Icon
11/16/2021Verition Fund Management LLC13,502$100K0.0%N/A0.102%Search for SEC Filing on Google Icon
10/28/2021180 Wealth Advisors LLC20,000$0.16M0.0%+33.3%0.151%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC18,938$100K0.0%+17.4%0.143%Search for SEC Filing on Google Icon
8/13/2021180 Wealth Advisors LLC15,000$70K0.0%N/A0.113%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC74,032$0.39M0.0%+153.3%0.558%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.109,158$0.58M0.0%+88.9%0.823%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC16,138$87K0.0%N/A0.122%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,349$83K0.0%N/A0.116%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC29,229$0.16M0.0%N/A0.222%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC74,100$0.32M0.0%N/A0.704%Search for SEC Filing on Google Icon
1/19/2021FNY Investment Advisers LLC75,000$0.32M0.1%-37.7%0.713%Search for SEC Filing on Google Icon
10/9/2020FNY Investment Advisers LLC120,407$0.97M0.4%N/A1.279%Search for SEC Filing on Google Icon
2/13/2020Renaissance Technologies LLC25,073$0.10M0.0%+59.2%0.334%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Edesa Biotech logo
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
Read More on Edesa Biotech

Today's Range

Now: $1.15
Low: $1.10
High: $1.18

50 Day Range

MA: $1.74
Low: $0.92
High: $2.33

52 Week Range

Now: $1.15
Low: $0.90
High: $8.95


115,119 shs

Average Volume

118,400 shs

Market Capitalization

$17.78 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Edesa Biotech?

Edesa Biotech's top insider shareholders include:
  1. Pardeep Nijhawan (CEO)
  2. Michael J Brooks (President)
  3. Frank R Oakes (Director)
Learn More about top insider investors at Edesa Biotech.